MFA Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Sell
3,836
-4,661
-55% -$268K 0.13% 125
2026
Q1
$515K Buy
8,497
+281
+3% +$16.4K 0.34% 77
2025
Q4
$443K Buy
8,216
+1,502
+22% +$72.3K 0.3% 80
2025
Q3
$303K Buy
6,714
+368
+6% +$17.2K 0.21% 92
2025
Q2
$294K Buy
6,346
+24
+0.4% +$1.18K 0.22% 92
2025
Q1
$386K Sell
6,322
-38
-0.6% -$2.21K 0.32% 77
2024
Q4
$360K Buy
+6,360
New +$355K 0.29% 79

Other funds holding BMY

MFA Wealth Services's BMY Position: Q2 2026 in Review

MFA Wealth Services reduced its Bristol-Myers Squibb (BMY) stake by 55% in Q2 2026, selling an estimated $268K and leaving 3,836 shares worth $221K. The position accounts for 0.13% of the portfolio, ranked #125.

MFA Wealth Services first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $515K in Q1 2026. 624 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • MFA Wealth Services held 3,836 shares of Bristol-Myers Squibb worth $221K as of Q2 2026.
  • MFA Wealth Services sold 4,661 Bristol-Myers Squibb shares in Q2 2026, an estimated $268K.
  • Bristol-Myers Squibb made up 0.13% of MFA Wealth Services's portfolio in Q2 2026, its #125 holding.
  • MFA Wealth Services first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • MFA Wealth Services's Bristol-Myers Squibb position peaked at $515K in Q1 2026.
  • 624 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MFA Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.